Recent advances in vaccines for leishmaniasis
- 1 September 2004
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 4 (9) , 1505-1517
- https://doi.org/10.1517/14712598.4.9.1505
Abstract
The observation that recovery from infection with Leishmania confers immunity to reinfection suggests that control of leishmaniasis by vaccination may be possible. However, there are no vaccines available at present to control any form of leishmaniasis, despite considerable efforts. Studies of the immunopathogenesis and mechanisms of protective immunity, mainly derived from animal models of experimental leishmaniasis, have defined a number of features that should be met by an effective vaccine. In addition, several antigens have been identified that may be potential vaccine candidates, and molecular biological techniques have made them available as recombinant proteins for second-generation vaccines. Furthermore, molecules present in the saliva of Leishmania-transmitting vectors have been demonstrated as valuable candidates for the development of anti-Leishmania vaccines. This review concentrates on the most promising vaccine candidates and highlights new approaches for the development of vaccines. Finall...Keywords
This publication has 78 references indexed in Scilit:
- Virulence and disease in leishmaniasis: what is relevant for the patient?Trends in Parasitology, 2004
- Identification of a Compensatory Mutant ( lpg2 − REV ) of Leishmania major Able To Survive as Amastigotes within Macrophages without LPG2 -Dependent Glycoconjugates and Its Significance to Virulence and Immunization StrategiesInfection and Immunity, 2004
- The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgroundsInternational Journal for Parasitology, 2004
- Protection against Cutaneous Leishmaniasis in Outbred Vervet Monkeys, Using a Recombinant Histone H1 AntigenThe Journal of Infectious Diseases, 2003
- A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantumVeterinary Immunology and Immunopathology, 2003
- Dendritic Cell-Based Vaccination Strategies: Induction of Protective Immunity against LeishmaniasisImmunobiology, 2001
- The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile CureThe Journal of Experimental Medicine, 2001
- Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c miceVaccine, 2001
- Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster modelVeterinary Immunology and Immunopathology, 2000
- Long-term protection of mice against Leishmania major with a synthetic peptide vaccineVaccine, 1999